Centaura's human artificial chromosome to treat complex diseases, including ageing
Medium - 10-Sep-2021A breakthrough technology focusing on effective gene therapies for healthy longevity
Join the club for FREE to access the whole archive and other member benefits.
Gene engineering specialist and Postdoctoral researcher at the Broad Institute of MIT and Harvard
A molecular biologist specialized in gene therapy and cell engineering. Chan is a Postdoctoral researcher at the Broad Institute of MIT and Harvard, and is currently working as a consultant on the development of Human Artificial Chromosomes (HAC).
Chan holds a PhD and B.Sc in Biochemistry and Molecular Biology from the University of British Columbia.
Visit website: https://giving.broadinstitute.org/broadignite/team/alina-chan
See also: Broad Institute of MIT and Harvard - Collaborative organization that brings academics of various disciplines in the scientific community together
Details last updated 19-Sep-2021
A breakthrough technology focusing on effective gene therapies for healthy longevity